What is the current stock price of NeurAxis, Inc. (NRXS)?

As of the latest market data, NeurAxis, Inc. (NRXS) is trading at $6.84. The stock has seen a loss of -5.66% today.

Does NeurAxis, Inc. (NRXS) pay a dividend?

Based on current data, NeurAxis, Inc. does not have a confirmed active dividend policy.

What is the market cap of NeurAxis, Inc.?

The current market capitalization of NeurAxis, Inc. (NRXS) is approximately unavailable.

NRXS

NeurAxis, Inc.·Healthcare

6.84

5.655%(−0.41)

Market Closed

7.54

10.234%(+0.70)

After Hours

Last Updated: — ET

52W L: $1.3352W H: $7.97

NRXS NEWS

globenewswire.com

1d ago

NeurAxis, Inc. Announces Preferred Stock Dividend

CARMEL, Ind., April 10, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced that on April 10, 2026, its Board of Directors declared a dividend on its Series B Preferred Stock.

zacks.com

Mar 24

NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth

NRXS witnesses strong revenue growth and expanding coverage in fourth-quarter 2025, but rising costs and commercialization investments weigh on profitability.

seekingalpha.com

Mar 19

NeurAxis, Inc. (NRXS) Q4 2025 Earnings Call Transcript

globenewswire.com

Mar 19

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results

CARMEL, Ind., March 19, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the fourth quarter period and full year ended December 31, 2025.

defenseworld.net

Jan 23

NeurAxis (NASDAQ:NRXS) Trading Down 5.7% – Here’s What Happened

NeurAxis, Inc. (NASDAQ: NRXS - Get Free Report) fell 5.7% during trading on Thursday. The company traded as low as $4.54 and last traded at $4.63. 136,167 shares changed hands during mid-day trading, an increase of 4% from the average session volume of 130,490 shares. The stock had previously closed at $4.91. Analyst Upgrades and

Company Profile

NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2023-08-09

Beta

1.89

Websiteneuraxis.com↗